Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
3 Ultra-Cheap Stocks That Could Get a Boost From Fed Rate Cuts
05:41am, Tuesday, 24'th Sep 2024
Lower interest rates can make dividend stocks such as Pfizer and Verizon more attractive investment options. Falling rates can reduce companies' interest expenses, which can help Carnival better manag
Pfizer: Oncology Breakthroughs, GLP-1, and Strategic M&A Insights with CFO Dave Denton
12:54pm, Monday, 23'rd Sep 2024
In the latest episode of After Earnings, Pfizer CFO Dave Denton shares insights into the company's achievements and future strategies with Ann Berry and Katie Perry. They discuss topics like acquiring
PFE & BNTX Get Positive CHMP Opinion for Updated COVID-19 Jab
10:56am, Monday, 23'rd Sep 2024
The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated version of mRNA COVID-19 jab, Comirnaty.
Pfizer: Undervalued Healthcare Leader Poised For Further Recovery
09:05am, Monday, 23'rd Sep 2024
Pfizer's transition from COVID revenue faces skepticism, as PFE underperformed its healthcare peers recently. Successful integration of Seagen is crucial for Pfizer's oncology portfolio, potentially l
Pfizer Is Rising Past Covid-19
09:00am, Monday, 23'rd Sep 2024
Pfizer Inc. (PFE, Financial) rose to prominence during the Covid-19 pandemic for its rapid development of a vaccine and antiviral therapy, establishing a household name in the process. As the pandemic
2 Beaten-Down Stocks to Buy and Hold for a Decade
06:00am, Monday, 23'rd Sep 2024
Pfizer and Moderna have seen their shares drop as their coronavirus-related tailwind ended. Yet, both companies have exciting pipelines and have earned important approvals recently.
3 Dirt Cheap Stocks to Buy Right Now
07:36am, Saturday, 21'st Sep 2024
CRISPR Therapeutics is still in its early stages of growth. Gilead Sciences remains an underrated stock.
Here's Why Pfizer (PFE) Fell More Than Broader Market
06:50pm, Friday, 20'th Sep 2024
In the closing of the recent trading day, Pfizer (PFE) stood at $29.42, denoting a -0.83% change from the preceding trading day.
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 3% Dividend Yields
09:00am, Friday, 20'th Sep 2024
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
08:11am, Friday, 20'th Sep 2024
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron KP.2-adapted COVID-19 Vaccine in the European Union
08:10am, Friday, 20'th Sep 2024
Upon authorization by the European Commission, the Omicron KP.2-adapted COVID-19 vaccine will be available for individuals 6 months of age and older Data demonstrate that the Omicron KP.2-adapted COVI
Pfizer Stock Rises 7.3% in 3 Months: Should You Invest Now?
10:05am, Thursday, 19'th Sep 2024
PFE's non-COVID drugs and potential contribution from new and newly acquired products have started to drive growth.
5 Incredible Healthcare High-Yield Blue-Chip Bargain Buys For 2025
07:00am, Thursday, 19'th Sep 2024
Healthcare is undervalued despite being the top sector for earnings growth, making it an attractive investment with solid fundamentals and the potential for explosive returns in 2025. Investing in hea
3 Magnificent Dividend Stocks With Yields Above 5% to Buy Now and Hold Forever
06:57am, Wednesday, 18'th Sep 2024
Now that W.P. Carey is no longer in the office-leasing business, its long-term investors can rest much easier.
Is Pfizer Stock Going to $36? 1 Wall Street Analyst Thinks So.
04:17pm, Monday, 16'th Sep 2024
The healthcare giant was a star stock during the height of the pandemic thanks to its vaccine. Some Pfizer investors are hungry for an encore and showing their displeasure by shunning the stock.
